Education
About Us
Working with TipRanks
Follow Us
Lee's Pharmaceutical Holdings Limited (HK:0950)
:0950
0950 Stock Chart & Stats
HK$1.60
-HK$0.01(-0.76%)
At close: 4:00 PM EST
HK$1.60
-HK$0.01(-0.76%)
Day’s Range― - ―
52-Week RangeHK$1.15 - HK$2.70
Previous CloseN/A
Volume7.00K
Average Volume (3M)5.40M
Market Cap
HK$942.14M
Enterprise ValueHK$667.93M
Total Cash (Recent Filing)HK$303.58M
Total Debt (Recent Filing)HK$243.63M
Price to Earnings (P/E)9.6
Beta0.63
Next Earnings
Mar 26, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield2.8%
Share Statistics
EPS (TTM)0.11
Shares Outstanding588,835,300
10 Day Avg. Volume4,101,801
30 Day Avg. Volume5,400,283
Financial Highlights & Ratios
PEG Ratio0.02
Price to Book (P/B)0.51
Price to Sales (P/S)0.60
P/FCF Ratio24.27
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusHold
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Lee's Pharmaceutical Holdings Limited News
0950 FAQ
What was Lee's Pharmaceutical Holdings Limited’s price range in the past 12 months?
Lee's Pharmaceutical Holdings Limited lowest stock price was HK$1.15 and its highest was HK$2.70 in the past 12 months.
What is Lee's Pharmaceutical Holdings Limited’s market cap?
Lee's Pharmaceutical Holdings Limited’s market cap is HK$942.14M.
When is Lee's Pharmaceutical Holdings Limited’s upcoming earnings report date?
Lee's Pharmaceutical Holdings Limited’s upcoming earnings report date is Mar 26, 2026 which is in 97 days.
How were Lee's Pharmaceutical Holdings Limited’s earnings last quarter?
Lee's Pharmaceutical Holdings Limited released its earnings results on Aug 26, 2025. The company reported HK$0.114 earnings per share for the quarter, beating the consensus estimate of N/A by HK$0.114.
Is Lee's Pharmaceutical Holdings Limited overvalued?
According to Wall Street analysts Lee's Pharmaceutical Holdings Limited’s price is currently Overvalued.
Does Lee's Pharmaceutical Holdings Limited pay dividends?
Lee's Pharmaceutical Holdings Limited pays a Quarterly dividend of HK$0.022 which represents an annual dividend yield of 2.8%. See more information on Lee's Pharmaceutical Holdings Limited dividends here
What is Lee's Pharmaceutical Holdings Limited’s EPS estimate?
Lee's Pharmaceutical Holdings Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Lee's Pharmaceutical Holdings Limited have?
Lee's Pharmaceutical Holdings Limited has 588,835,300 shares outstanding.
What happened to Lee's Pharmaceutical Holdings Limited’s price movement after its last earnings report?
Lee's Pharmaceutical Holdings Limited reported an EPS of HK$0.114 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -1%.
Which hedge fund is a major shareholder of Lee's Pharmaceutical Holdings Limited?
Currently, no hedge funds are holding shares in HK:0950
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Lee's Pharmaceutical Holdings Limited Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
57.67%
12-Months-Change
Fundamentals
Return on Equity
5.35%
Trailing 12-Months
Asset Growth
17.56%
Trailing 12-Months
Company Description
Lee's Pharmaceutical Holdings Limited
Lee's Pharmaceutical Holdings Limited (0950) is a Hong Kong-based biopharmaceutical company that focuses on the research, development, manufacturing, and commercialization of innovative drugs and specialty pharmaceuticals. The company operates primarily in the fields of oncology, cardiovascular, and metabolic diseases, as well as offering a range of generic and proprietary pharmaceuticals. Lee's Pharmaceutical is dedicated to improving healthcare outcomes through the development of high-quality, affordable medications and has established a strong presence in both local and international markets.
Technical Analysis
Sihuan Pharmaceutical Holdings Group
―
―
Dawnrays Pharmaceutical Holdings Ltd.
―
China Shineway Pharmaceutical Group Limited
―
Shandong Xinhua Pharmaceutical Company Limited Class H
―
Options Prices
Currently, No data available
---